1[1]Wenning GK,Odin P,Morrish P et al. Short-and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson disea se.Ann Neurol,1997;42:95
2[2]Clarkson ED,Zawada WM,Adams FS et al. Strand of embryonic mesencephlic tissue show greater dopamine neuron survival and better behavioral improvement t han cell suspensions after transplantation in Parkinsonian rats.Brain Res,1998;8 06:60
3[3]Hagell P,Schrag A,Piccini P et al. Sequential bilateral transplantation in Parkinsons disease:effects of the second graft.Brain,1999;122(Pt6):1121
4[4]Starr PA,Wichmann T,van Horne C et al. Intranigral transplantation of f et al substantia nigra allograft in the hemiparkinsonian rhesus monkey.Cell Transpl ant,1999;8(1):37
5[5]Kopyov OV,Jacques DS Lieberman A et al. Outcome following intrastriatal fetal mesencephalic grafts for Parkinson patients is directly related to the vo lume of grafted tissue.Exp Neurol,1997;146(2):536
6[6]Roitberg B.Cell transplantation in the central nervous system.Surg Neurol,1 999;52:13
7[7]Clarkson ED,Freed CR.Development of fetal neural transplantation as a treat ment for Parkinson disease.Life Sciences,1999;65(23):2427
8[8]Lopez-Lozano JJ,Bravo G, Brera B et al. Regression of parkinsonian fetal ventral mesencephalon grafts upon withdrawal of cyclosporine A immunosupp ression.Transplant Proc,1997,29(1-2):977
9[9]Branton RL,Clarke DJ.Apoptosis in primary cultures of E14 rat ventral mesen cephala:time course of dopaminergic cell death and implications for neural trans plantation.Exp Neurol,1999;160(1):88
10[10]Kaminski Schierle GS,Hansson O,Brundin P.Flunarizine improves the su rvival of grafted dopaminergic neurons.Neuroscience,1999;94(1):17
